Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors

[1]  G. Shaw,et al.  Type-specific antigens for serological discrimination of HTLV-I and HTLV-II infection , 1990, The Lancet.

[2]  W. Blattner,et al.  Isolation of human T-cell lymphotropic virus type 2 from Guaymi Indians in Panama. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[3]  F. Lori,et al.  HTLV-II infection in Italian drug abusers , 1990, The Lancet.

[4]  W. Blattner,et al.  Patterns of HIV-1 and HTLV-I/II in intravenous drug abusers from the middle atlantic and central regions of the USA. , 1990, The Journal of infectious diseases.

[5]  B. Hjelle,et al.  High frequency of human T-cell leukemia-lymphoma virus type II infection in New Mexico blood donors: determination by sequence-specific oligonucleotide hybridization. , 1990, Blood.

[6]  J. Giorgi,et al.  A clinical, hematologic, and immunologic analysis of 21 HTLV-II-infected intravenous drug users. , 1990, Blood.

[7]  J. Epstein,et al.  Serological confirmation of human T-lymphotropic virus type I infection in healthy blood and plasma donors. , 1989, Blood.

[8]  J. Sninsky,et al.  Prevalence of human T-cell leukemia/lymphoma virus (HTLV) type II infection among high-risk individuals: type-specific identification of HTLVs by polymerase chain reaction. , 1989, Blood.

[9]  D. Ho,et al.  Markers of HIV infection prior to IgG antibody seropositivity. , 1989, JAMA.

[10]  H. Lee,et al.  Human immunodeficiency virus and human T-cell leukemia virus type I in patients undergoing maintenance hemodialysis in Miami. , 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  J. Zack,et al.  High rate of HTLV-II infection in seropositive i.v. drug abusers in New Orleans. , 1989, Science.

[12]  D. Slamon,et al.  Seroprevalence and epidemiological correlates of HTLV-I infection in U.S. blood donors. , 1988, Science.

[13]  W. Wachsman,et al.  Integrated human T-cell leukemia virus II genome in CD8 + T cells from a patient with "atypical" hairy cell leukemia: evidence for distinct T and B cell lymphoproliferative disorders. , 1988, Blood.

[14]  E. Delaporte,et al.  Human T-cell leukemia virus type I isolates from Gabon and Ghana: comparative analysis of proviral genomes. , 1987, Virology.

[15]  S. Izumo,et al.  Chronic progressive myelopathy associated with elevated antibodies to human T‐lymphotropic virus type I and adult T‐cell leukemialike cells , 1987, Annals of neurology.

[16]  W. Wachsman,et al.  A second isolate of HTLV-II associated with atypical hairy-cell leukemia. , 1986, The New England journal of medicine.

[17]  G. Dawson,et al.  Performance evaluation of the Abbott HTLV III EIA, a test for antibody to HTLV III in donor blood. , 1986, American journal of clinical pathology.

[18]  S. Weiss,et al.  Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region. , 1986, JAMA.

[19]  R. Biggar,et al.  Regional variation in prevalence of antibody against human T‐lymphotropic virus types I and III in Kenya, East Africa , 1985, International journal of cancer.

[20]  G. Shaw,et al.  Nucleotide sequence analysis of a variant human T-cell leukemia virus (HTLV-Ib) provirus with a deletion in pX-I , 1985, Journal of virology.

[21]  Tsutomu Yoshida,et al.  Seroepidemilogy of human T‐lymphotropic retrovirus type I (HTLV‐I) in residents of niigata prefecture, Japan. Comparative studies by indirect immunofluorescence microscopy and enzyme‐linked immunosorbent assay , 1985, International journal of cancer.

[22]  D. Jeffries,et al.  LOW PREVALENCE IN THE UK OF HTLV-I AND HTLV-II INFECTION IN SUBJECTS WITH AIDS, WITH EXTENDED LYMPHADENOPATHY, AND AT RISK OF AIDS , 1984, The Lancet.

[23]  D. Golde,et al.  Molecular characterization of genome of a novel human T-cell leukaemia virus , 1983, Nature.

[24]  M. Yoshida,et al.  Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[25]  E. Jaffe,et al.  Epidemiology of human T-cell leukemia/lymphoma virus. , 1983, The Journal of infectious diseases.

[26]  M. Robert-Guroff,et al.  A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. , 1982, Science.

[27]  W. Blattner,et al.  The human type‐C retrovirus, HTLV, in blacks from the Caribbean region, and relationship to adult T‐cell leukemia/lymphoma , 1982, International journal of cancer.

[28]  J. Lipton,et al.  Separation of different molecular forms of macrophage‐ and granulocyte‐inducing proteins for normal and leukemic myeloid cells , 1980, International journal of cancer.

[29]  V. Feron,et al.  Significance of particle size of benzo(a)pyrene for the induction of respiratory tract tumours in hamsters , 1980, International journal of cancer.

[30]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.